Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New ovine enzootic abortion vaccine in development
"We are very encouraged by the new vaccine results." - Dr David Longbottom.
The work is led by Dr David Longbottom, of the Moredun Research Institute. 

Scientists at the Moredun Research Institute are developing a new vaccine against ovine enzootic abortion.

Ovine enzootic abortion is the most common cause of abortion in sheep in the UK, and is caused by the bacteria Chlamydia abortus, which invades the placenta during pregnancy. The disease can also cause life-threatening illness and abortion in humans.

The disease spreads through ingestion and inhalation, and a high level of environmental contamination by infected ewes in lambing pens is a key point in the spread of disease.

Led by Dr David Longbottom, the scientists at Moredun have completed the first stage in the development of the vaccine, which is similar to the live variation, but does not possess the ability to grow and cause infections in the host animal. 

Dr Longbottom commented on the ongoing development process: “We are very encouraged that the new vaccine results in a similar protective response to that generated following a natural infection or resulting from the live vaccines but importantly without the ability to cause disease.”

More about the vaccine can be read in this study, published in Vaccines

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."